Heparin Resistance: Predictors and Outcomes

Heparin Resistance During Off-pump Coronary Artery Bypass Graft Surgery: Predictors and Clinical Implication

NCT01044888•Yonsei University

Summary

The investigators evaluated clinical impact of reduced heparin responsiveness (HRreduced) on the incidence of perioperative myocardial infarction (MI) and restenosis at 6 months after off-pump coronary artery bypass graft surgery (OPCAB) and identified its predictors.

Eligibility

Age

18 - 85 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•enrolling all consecutive patients scheduled for elective isolated multivessel OPCAB between April 2007 and March 2008

Exclusion Criteria

•presence of known preoperative coagulopathy, emergency operation or preoperative use of an intra-aortic balloon pump.

Locations (1)

Yonsei University Severance hospital

Seoul, Seodaemungu, South Korea

Key Dates

Start Date

April 1, 2007

Primary Completion Date

March 1, 2008

Completion Date

September 1, 2008

Last Updated

February 2, 2012

Enrollment

199

ACTUAL participants

Conditions

Off Pump Coronary Artery Bypass Surgery

Interventions

Heparin

DRUG

Tranexamic Acid in Off-pump Coronary Surgery

NCT01064167

Off Pump Coronary Artery Bypass Surgery

View study

UNKNOWNNA

Clinical Evaluation of LeGoo™ Internal Vessel Occluder Versus Traditional Vessel Loops

NCT00985634

Off Pump Coronary Artery Bypass Surgery

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: February 2, 2012Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions